Asep Medical Holdings Inc
SEPSF · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 1.1% | 0% | 250% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 54.9% | 46.8% | -342.3% | -259.1% |
| R&D Expenses | $0 | $0 | -$0 | $0 |
| G&A Expenses | $0 | $1 | $1 | $1 |
| SG&A Expenses | $0 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $2 |
| Operating Income | -$1 | -$1 | -$1 | -$2 |
| % Margin | -1,184.2% | -1,781.5% | -1,239.2% | -8,873.3% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$1 | -$1 | -$1 | -$2 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | -$1 | -$1 | -$1 | -$2 |
| % Margin | -980.4% | -1,516.8% | -1,029.9% | -9,543.8% |
| EPS | -0.01 | -0.015 | -0.01 | -0.027 |
| % Growth | 34.7% | -44.1% | 62.5% | – |
| EPS Diluted | -0.01 | -0.015 | -0.01 | -0.027 |
| Weighted Avg Shares Out | 76 | 76 | 75 | 74 |
| Weighted Avg Shares Out Dil | 76 | 76 | 75 | 74 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$1 | -$1 | -$2 |
| % Margin | -851.5% | -1,361.7% | -818.5% | -9,341.1% |